General Atlantic
VC Fund
New York, United States
General Atlantic is a VC fund in New York focused on Software and E-Commerce. General Atlantic deploys capital across growth equity, credit, energy transition, and infrastructure strategies to help businesses expand their operations. Through dedicated functional teams, the organization delivers strategic advisory services in areas such as go-to-market execution, capital markets, pricing strategy, commercial diligence, and talent management.
- Total investments:
- 597
- Last investment:
- Lead investor:
- 64%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries General Atlantic invests in
Stages General Atlantic invests in
Countries General Atlantic invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 48 contacts → | |||
Round size
- Series B
- $35M–$226M
- Series C
- $50M–$300M
- Private Equity
- $61M–$1.5B
Investment Focus
Industry
- Software 72 (12%)
- E-Commerce 54 (9%)
- Health Care 52 (9%)
- Financial Services 46 (8%)
- FinTech 42 (7%)
Stage
- Private Equity 139 (23%)
- Series C 58 (10%)
- Series B 51 (9%)
- Series E 40 (7%)
- Series D 38 (6%)
Country
- United States 176 (29%)
- India 29 (5%)
- China 26 (4%)
- Brazil 18 (3%)
- United Kingdom 15 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Alex Crisses
Managing Director, Global Head of New Investment Sourcing & Co-Head of Emerging Growth
|
Managing Director, Global Head of New Investment Sourcing & Co-Head of Emerging Growth | Total investments: 12 | Find email | |
Andrea W. Joseph
Managing Director
|
Managing Director | Total investments: 0 | Find email | |
Andrew Crawford
Managing Director and Global Head of Consumer
|
Managing Director and Global Head of Consumer | Total investments: 12 | Find email | |
Asher Hecht
Vice President
|
Vice President | Total investments: 2 | Find email | |
Ashish Saboo
Managing Director, Chief Representative of Indonesia
|
Managing Director, Chief Representative of Indonesia | Total investments: 2 | Find email | |
| See all 48 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Korsana Biosciences develops THETA-enabled antibody therapies for neurodegenerative diseases. The company focuses on shuttled monoclonal antibodies that cross the blood-brain barrier to reach central nervous system targets. Its lead program, KRSA-028, is an investigational anti-amyloid beta antibody for Alzheimer’s disease that uses a transferrinreceptor-based shuttle and Fc engineering to improve brain delivery and dosing. Korsana is also advancing additional THETA-based programs for undisclosed neurodegenerative indications. | $380M / Post-IPO Equity / Sep 08, 2026 | ||
|
Chariot Reinsurance
|
Chariot Reinsurance is a life and annuity reinsurance company. | $700M / Private Equity / Sep 02, 2026 | |
|
Chariot Reinsurance
|
Chariot Reinsurance is a life and annuity reinsurance company. | Debt Financing / Sep 02, 2026 | |
| Blank Street is a coffee chain that offers coffee as a daily ritual that more people can enjoy, in places convenient to their lives. Its automated espresso machines consistently produce consistent coffee, allowing baristas to be more interactive and build relationships. Customers can order ahead of time using their app, streamlining theirexperience. Their vendors (outsourced milk and pastries) are excellent, allowing them to concentrate on the coffee. | $75M / Series C / Aug 23, 2026 | ||
| Avere Therapeutics is a biotechnology company that develops oral interleukin-23 receptor antagonist therapies for chronic inflammatory diseases. The company is advancing AVR-001, an oral, once-weekly IL-23 receptor antagonist designed to modulate IL-23 signaling. Its work focuses on leveraging a validated immunology target with clinical proof ofconcept across conditions such as psoriasis, ulcerative colitis, Crohn’s disease, and psoriatic arthritis. Avere Therapeutics concentrates on achieving convenient dosing while maintaining efficacy through higher and more consistent drug exposure and a longer half-life. Its programs are intended to offer pill-based treatment options for patients who currently rely on injectable IL-23 inhibitors. | $500M / Private Equity / Aug 10, 2026 | ||
| Expedition Therapeutics operates as an unincorporated association. | $115M / Series B / Aug 05, 2026 | ||
| Gravie is a health benefits platform that offers insurance services. Their software products include Comfort and Ichra. Gravie designed health benefits to help employers control costs. They take a defined contribution approach, to employers set a fixed budget each year. | $50M / Private Equity / Jul 30, 2026 | ||
| SambaNova develops artificial intelligence computing infrastructure that combines AI processors, hardware systems, and software for deploying and managing AI inference workloads. Its platform supports cloud, on-premises, and hybrid deployments, enabling organizations to run and manage large language models and AI applications using compatible APIsand orchestration tools. | $1B / Series F / Jul 08, 2026 | ||
| Chess.com is an online community for chess players. Community members use the website to learn and discuss strategy, and play each other in real-time or by correspondence. | Private Equity / Jun 25, 2026 | ||
| Westcon-Comstor (WestconGroup Inc.) is a value-added technology distributor of category-leading solutions in Security, Collaboration, Networking and Data Center. The company is transforming the technology supply chain through its capabilities in Cloud, Services and Global Deployment. Through a unique physical and digital distribution network,Westcon-Comstor extends its partners' global reach while providing the local expertise needed to successfully navigate worldwide opportunities. The company combines expert technical and market knowledge with industry-leading partner enablement programs. Westcon-Comstor delivers results together through its unique engagement model and deep partner relationships. The company goes to market under the Westcon and Comstor brands. | Private Equity / Jun 19, 2026 | ||
| See all 597 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does General Atlantic invest in?
General Atlantic invests primarily in Software, E-Commerce and Health Care startups, most often at Private Equity and Series C stage. Most of the 597 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does General Atlantic invest in?
General Atlantic typically joins rounds of $35M–$226M at Series B, $50M–$300M at Series C and $61M–$1.5B at Private Equity. These are whole funding-round sizes, not General Atlantic's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds General Atlantic took part in.
How do I contact General Atlantic?
Public channels for General Atlantic include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at General Atlantic?
The team at General Atlantic includes Alex Crisses (Managing Director, Global Head of New Investment Sourcing & Co-Head of Emerging Growth), Andrea W. Joseph (Managing Director) and Andrew Crawford (Managing Director and Global Head of Consumer), among 48 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
